The market size of Chronic Lower Back Pain in the 7MM is expected to grow at a CAGR of 3.55% for the study period, 2017– 2030.
Among the 7MM countries, the United States had the highest market size of Chronic lower back pain (CLBP) in 2017, which accounts for approximately 62.18% of the total market.
In 2017, the total Prevalent Population of Chronic lower back pain (CLBP) in the 7MM was found to be 73,802,461.
The key players in Chronic Lower Back Pain (CLBP) Market includes Braeburn Pharmaceuticals, Camurus, Regeneron Pharmaceuticals, Teva Pharmaceutical, Pfizer, Eli Lilly and Company, Mesoblast, Egalet Corporation, Axsome Therapeutics, Allodynic Therapeutics, Astellas Pharma, Grünenthal GmbH, Frontier Biotechnologies, DiscGenics, Yuhan Corporation, Semnur Pharmaceuticals, Sollis Therapeutics, SpineThera, Stayble Therapeutics, AnGes MG and many others.
For more detailed information visit:
https://www.delveinsight.com/report-store/chronic-lower-back-pain-clbp-market